An abnormal smear is not cancer. It is the opportunity to prevent it.

Millions of women receive an abnormal smear or a positive HPV test every year; only a small fraction have or will develop cancer. What matters is expert triage: colposcopy — the microscopic examination of the cervix — performed by a physician who knows precisely what to biopsy, what to treat, and what to safely observe. Overtreatment harms future pregnancies; undertreatment misses disease.

Prof. Erdemoğlu co-authored a Lancet publication on HPV-based prevention of invasive cervical cancer and has taught cervical pathology and colposcopy at university level for nearly two decades. He performs colposcopy, targeted biopsy, and treatment of precancerous lesions (LEEP/conization), with fertility-conscious technique in young women, and organizes follow-up according to current international (ASCCP/European) guidelines.

When to seek consultation:

HPV-positive test; ASC-US, LSIL, HSIL or AGC smear results; a biopsy showing CIN 2–3; follow-up after previous conization.